The Effect of Parkinson Kinetigraph Recordings on the Management and Outcome in Parkinson's Disease
Launched by SAHLGRENSKA UNIVERSITY HOSPITAL · May 12, 2017
Trial Information
Current as of August 11, 2025
Completed
Keywords
ClinConnect Summary
Patients that have previously not performed a PKG recording will be recruited from the WestPORTS community based cohort of outpatients with PD in West Sweden. The WestPORTS study includes self-assessments like PDQ8 and NMS-Q as well as PKG recordings. On inclusion in WestPORTS-Int subjects will be randomized by minimization for age, gender and disease duration into one of two study arms. In the intervention group the PKG recording of the subject will be made available, together with a summarized interpretation, to the subject's regular neurologist/geriatrician before the next scheduled visi...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. Clinical diagnosis of Parkinson's disease (ICD G209) according to medical records
- • 2. A visit to an outpatient neurological or geriatric clinic in the region Vastra Gotaland, Sweden within the last -1 to -7 months according to medical records.
- • 3. Randomized to invitation to participate in the WestPORTS objective measurement Cohort study (NCT03130595) by 1:4 randomization based on the full population fulfilling criteria 1 and 2.
- • 4. Written informed consent
- • 5. No previous PKG recording has been performed with the subject.
- Exclusion Criteria:
- • 1. Withdrawal of consent.
- • 2. Unable to wear a PKG on either wrist.
- • 3. The patient's physician is the PI of the study (F Bergquist)
About Sahlgrenska University Hospital
Sahlgrenska University Hospital, a leading healthcare institution in Sweden, is at the forefront of clinical research and innovation. Affiliated with the University of Gothenburg, the hospital integrates advanced medical care with cutting-edge research, facilitating a collaborative environment for scientific exploration and clinical trials. With a commitment to improving patient outcomes, Sahlgrenska University Hospital focuses on a wide range of therapeutic areas, leveraging its multidisciplinary expertise to advance healthcare solutions. The institution is dedicated to fostering ethical research practices and ensuring the highest standards of patient safety and care in all clinical trials.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Göteborg, , Sweden
Patients applied
Trial Officials
Filip Bergquist
Principal Investigator
Göteborg University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials